Amarin Corp Plc (AMRN)

[Tal10]

The market cap is amazing, especially compared to 12 months ago. But considering the addressable market, why not $15B, why not $25B, why not $50B? Are shorts strong enough to hold back such potential based on fear driven propaganda? Is this a short, short game until the FDA announcement that seems to be a lock at this point, and just a matter of what exactly will be on the label? I, like every other long, would like to think so, but are we letting this cloud our due diligence? I am by no means saying we don't have strong patent protection, I just want to know how Wall Street could think otherwise if this is not just a short, short game.